(Q34104373)

English

Factor IX and thrombosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Factor IX and thrombosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

author name string

Lowe GD

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

115

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

507-513

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Christmas disease: a condition previously mistaken for haemophilia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Thrombogenic materials in prothrombin complex concentrates.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Oral contraception and the detection of carriers in haemophilia B

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Hemophilia B Leyden: a sex-linked hereditary disorder that improves after puberty

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

A mutation in the propeptide of Factor IX leads to warfarin sensitivity by a novel mechanism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Recovery from Hemophilia B Leyden: An Androgen-Responsive Element in the Factor IX Promoter

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

The Value of Age‐ and Sex‐Matched Controls for Coagulation Studies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Antithrombotic efficacy of a novel murine antihuman factor IX antibody in rats.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

In vitro and in vivo correlation of clotting protease activity: Effect of heparin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Activation of intrinsic or extrinsic blood coagulation in experimental venous thrombosis and disseminated intravascular coagulation: Pathogenetic differences

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Increased sensitivity of factor IX to phenprocoumon as a cause of bleeding in a patient with antiphospholipid antibody associated thrombosis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Genetic mechanisms of age regulation of blood coagulation: factor IX model

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Inhibition of activated porcine factor IX by dansyl-glutamyl-glycyl-arginyl-chloromethylketone

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Haemophilia care in central Scotland 1980-94. I. Demographic characteristics, hospital admissions and causes of death

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Missense mutations at ALA-10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Mortality and causes of death in Dutch haemophiliacs, 1973-86.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Haemophilia protects against ischaemic heart disease: a study of risk factors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

The inheritance of Christmas factor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Differentiation of hemophilia into two groups; a study of thirty-three cases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Age-dependent effect on the level of factor IX.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

A cross-over pharmacokinetic and thrombogenicity study of a prothrombin complex concentrate and a purified factor IX concentrate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Association of vitamin K-dependent coagulation proteins and C4b binding protein with triglyceride-rich lipoproteins of human plasma.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03186.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2001.03186.X

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34104373&oldid=1539831820"